nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicyclomine—Benign prostatic hyperplasia—Rivastigmine—Alzheimer's disease	0.0339	0.0415	CcSEcCtD
Dicyclomine—Hallucination, visual—Galantamine—Alzheimer's disease	0.0327	0.0401	CcSEcCtD
Dicyclomine—Hallucination, visual—Rivastigmine—Alzheimer's disease	0.0225	0.0276	CcSEcCtD
Dicyclomine—Drug hypersensitivity—Memantine—Alzheimer's disease	0.0149	0.0183	CcSEcCtD
Dicyclomine—Delirium—Galantamine—Alzheimer's disease	0.00993	0.0122	CcSEcCtD
Dicyclomine—Delusion—Donepezil—Alzheimer's disease	0.00936	0.0115	CcSEcCtD
Dicyclomine—Paralysis—Memantine—Alzheimer's disease	0.00865	0.0106	CcSEcCtD
Dicyclomine—Delusion—Memantine—Alzheimer's disease	0.00849	0.0104	CcSEcCtD
Dicyclomine—Thrombosis—Rivastigmine—Alzheimer's disease	0.00831	0.0102	CcSEcCtD
Dicyclomine—Delusion—Rivastigmine—Alzheimer's disease	0.00831	0.0102	CcSEcCtD
Dicyclomine—Mania—Memantine—Alzheimer's disease	0.00827	0.0101	CcSEcCtD
Dicyclomine—Numbness—Donepezil—Alzheimer's disease	0.00799	0.00978	CcSEcCtD
Dicyclomine—Dermatitis atopic—Rivastigmine—Alzheimer's disease	0.00795	0.00973	CcSEcCtD
Dicyclomine—Necrosis—Memantine—Alzheimer's disease	0.00766	0.00938	CcSEcCtD
Dicyclomine—Sensory loss—Donepezil—Alzheimer's disease	0.00764	0.00936	CcSEcCtD
Dicyclomine—Ageusia—Rivastigmine—Alzheimer's disease	0.00726	0.00889	CcSEcCtD
Dicyclomine—Numbness—Memantine—Alzheimer's disease	0.00725	0.00888	CcSEcCtD
Dicyclomine—Apnoea—Memantine—Alzheimer's disease	0.00709	0.00868	CcSEcCtD
Dicyclomine—Speech disorder—Memantine—Alzheimer's disease	0.00699	0.00856	CcSEcCtD
Dicyclomine—Delirium—Memantine—Alzheimer's disease	0.00699	0.00856	CcSEcCtD
Dicyclomine—Sensory loss—Memantine—Alzheimer's disease	0.00694	0.0085	CcSEcCtD
Dicyclomine—Apnoea—Rivastigmine—Alzheimer's disease	0.00694	0.0085	CcSEcCtD
Dicyclomine—Speech disorder—Rivastigmine—Alzheimer's disease	0.00684	0.00837	CcSEcCtD
Dicyclomine—Delirium—Rivastigmine—Alzheimer's disease	0.00684	0.00837	CcSEcCtD
Dicyclomine—Dyskinesia—Memantine—Alzheimer's disease	0.0064	0.00783	CcSEcCtD
Dicyclomine—Lethargy—Galantamine—Alzheimer's disease	0.00633	0.00775	CcSEcCtD
Dicyclomine—Dyskinesia—Rivastigmine—Alzheimer's disease	0.00626	0.00766	CcSEcCtD
Dicyclomine—Urinary retention—Galantamine—Alzheimer's disease	0.0059	0.00722	CcSEcCtD
Dicyclomine—Muscular weakness—Galantamine—Alzheimer's disease	0.00547	0.0067	CcSEcCtD
Dicyclomine—Thrombophlebitis—Memantine—Alzheimer's disease	0.00504	0.00617	CcSEcCtD
Dicyclomine—Thrombophlebitis—Rivastigmine—Alzheimer's disease	0.00493	0.00604	CcSEcCtD
Dicyclomine—Disorientation—Memantine—Alzheimer's disease	0.00488	0.00597	CcSEcCtD
Dicyclomine—Affect lability—Donepezil—Alzheimer's disease	0.00473	0.00579	CcSEcCtD
Dicyclomine—Amnesia—Memantine—Alzheimer's disease	0.00465	0.00569	CcSEcCtD
Dicyclomine—Face oedema—Donepezil—Alzheimer's disease	0.00464	0.00568	CcSEcCtD
Dicyclomine—Urinary retention—Donepezil—Alzheimer's disease	0.00457	0.0056	CcSEcCtD
Dicyclomine—Mood swings—Donepezil—Alzheimer's disease	0.00455	0.00558	CcSEcCtD
Dicyclomine—Amnesia—Rivastigmine—Alzheimer's disease	0.00454	0.00556	CcSEcCtD
Dicyclomine—Lethargy—Memantine—Alzheimer's disease	0.00445	0.00545	CcSEcCtD
Dicyclomine—Diplopia—Memantine—Alzheimer's disease	0.00436	0.00534	CcSEcCtD
Dicyclomine—Affect lability—Memantine—Alzheimer's disease	0.0043	0.00526	CcSEcCtD
Dicyclomine—Diplopia—Rivastigmine—Alzheimer's disease	0.00427	0.00523	CcSEcCtD
Dicyclomine—Hallucination—Galantamine—Alzheimer's disease	0.00427	0.00523	CcSEcCtD
Dicyclomine—Muscular weakness—Donepezil—Alzheimer's disease	0.00424	0.00519	CcSEcCtD
Dicyclomine—Affect lability—Rivastigmine—Alzheimer's disease	0.0042	0.00515	CcSEcCtD
Dicyclomine—Abdominal distension—Donepezil—Alzheimer's disease	0.00418	0.00512	CcSEcCtD
Dicyclomine—Urinary retention—Memantine—Alzheimer's disease	0.00415	0.00508	CcSEcCtD
Dicyclomine—Mood swings—Memantine—Alzheimer's disease	0.00413	0.00506	CcSEcCtD
Dicyclomine—Face oedema—Rivastigmine—Alzheimer's disease	0.00412	0.00505	CcSEcCtD
Dicyclomine—Urinary retention—Rivastigmine—Alzheimer's disease	0.00406	0.00497	CcSEcCtD
Dicyclomine—Mood swings—Rivastigmine—Alzheimer's disease	0.00404	0.00495	CcSEcCtD
Dicyclomine—Eye disorder—Galantamine—Alzheimer's disease	0.00401	0.00491	CcSEcCtD
Dicyclomine—Cardiac disorder—Galantamine—Alzheimer's disease	0.00398	0.00488	CcSEcCtD
Dicyclomine—Immune system disorder—Galantamine—Alzheimer's disease	0.00388	0.00475	CcSEcCtD
Dicyclomine—Breast disorder—Rivastigmine—Alzheimer's disease	0.00386	0.00472	CcSEcCtD
Dicyclomine—Muscular weakness—Memantine—Alzheimer's disease	0.00385	0.00471	CcSEcCtD
Dicyclomine—Muscular weakness—Rivastigmine—Alzheimer's disease	0.00377	0.00461	CcSEcCtD
Dicyclomine—Mental disorder—Galantamine—Alzheimer's disease	0.00376	0.0046	CcSEcCtD
Dicyclomine—Tension—Galantamine—Alzheimer's disease	0.00367	0.00449	CcSEcCtD
Dicyclomine—Nervousness—Galantamine—Alzheimer's disease	0.00363	0.00444	CcSEcCtD
Dicyclomine—Vision blurred—Galantamine—Alzheimer's disease	0.00352	0.00431	CcSEcCtD
Dicyclomine—Erectile dysfunction—Memantine—Alzheimer's disease	0.00347	0.00425	CcSEcCtD
Dicyclomine—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00347	0.00424	CcSEcCtD
Dicyclomine—Agitation—Galantamine—Alzheimer's disease	0.00343	0.0042	CcSEcCtD
Dicyclomine—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.0034	0.00416	CcSEcCtD
Dicyclomine—Malaise—Galantamine—Alzheimer's disease	0.00337	0.00412	CcSEcCtD
Dicyclomine—Syncope—Galantamine—Alzheimer's disease	0.00335	0.0041	CcSEcCtD
Dicyclomine—Hypoaesthesia—Donepezil—Alzheimer's disease	0.00331	0.00405	CcSEcCtD
Dicyclomine—Hallucination—Donepezil—Alzheimer's disease	0.00331	0.00405	CcSEcCtD
Dicyclomine—Palpitations—Galantamine—Alzheimer's disease	0.0033	0.00404	CcSEcCtD
Dicyclomine—Drowsiness—Rivastigmine—Alzheimer's disease	0.00329	0.00403	CcSEcCtD
Dicyclomine—Loss of consciousness—Galantamine—Alzheimer's disease	0.00328	0.00402	CcSEcCtD
Dicyclomine—Hypertension—Galantamine—Alzheimer's disease	0.00323	0.00395	CcSEcCtD
Dicyclomine—Discomfort—Galantamine—Alzheimer's disease	0.00314	0.00385	CcSEcCtD
Dicyclomine—Dry mouth—Galantamine—Alzheimer's disease	0.00311	0.00381	CcSEcCtD
Dicyclomine—Confusional state—Galantamine—Alzheimer's disease	0.00307	0.00376	CcSEcCtD
Dicyclomine—Hypoaesthesia—Memantine—Alzheimer's disease	0.003	0.00368	CcSEcCtD
Dicyclomine—Hallucination—Memantine—Alzheimer's disease	0.003	0.00368	CcSEcCtD
Dicyclomine—Shock—Galantamine—Alzheimer's disease	0.003	0.00367	CcSEcCtD
Dicyclomine—Nervous system disorder—Galantamine—Alzheimer's disease	0.00299	0.00366	CcSEcCtD
Dicyclomine—Tachycardia—Galantamine—Alzheimer's disease	0.00298	0.00364	CcSEcCtD
Dicyclomine—Hallucination—Rivastigmine—Alzheimer's disease	0.00294	0.0036	CcSEcCtD
Dicyclomine—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.00294	0.0036	CcSEcCtD
Dicyclomine—Mental disorder—Donepezil—Alzheimer's disease	0.00291	0.00357	CcSEcCtD
Dicyclomine—Anorexia—Galantamine—Alzheimer's disease	0.00291	0.00356	CcSEcCtD
Dicyclomine—Erythema—Donepezil—Alzheimer's disease	0.00289	0.00354	CcSEcCtD
Dicyclomine—Tension—Donepezil—Alzheimer's disease	0.00284	0.00348	CcSEcCtD
Dicyclomine—Eye disorder—Memantine—Alzheimer's disease	0.00282	0.00345	CcSEcCtD
Dicyclomine—Nervousness—Donepezil—Alzheimer's disease	0.00281	0.00344	CcSEcCtD
Dicyclomine—Cardiac disorder—Memantine—Alzheimer's disease	0.0028	0.00343	CcSEcCtD
Dicyclomine—Eye disorder—Rivastigmine—Alzheimer's disease	0.00276	0.00338	CcSEcCtD
Dicyclomine—Insomnia—Galantamine—Alzheimer's disease	0.00276	0.00338	CcSEcCtD
Dicyclomine—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00274	0.00336	CcSEcCtD
Dicyclomine—Paraesthesia—Galantamine—Alzheimer's disease	0.00274	0.00335	CcSEcCtD
Dicyclomine—Vision blurred—Donepezil—Alzheimer's disease	0.00273	0.00334	CcSEcCtD
Dicyclomine—Immune system disorder—Memantine—Alzheimer's disease	0.00273	0.00334	CcSEcCtD
Dicyclomine—Mediastinal disorder—Memantine—Alzheimer's disease	0.00272	0.00333	CcSEcCtD
Dicyclomine—Somnolence—Galantamine—Alzheimer's disease	0.00271	0.00332	CcSEcCtD
Dicyclomine—Ill-defined disorder—Donepezil—Alzheimer's disease	0.00269	0.00329	CcSEcCtD
Dicyclomine—Dyspepsia—Galantamine—Alzheimer's disease	0.00268	0.00329	CcSEcCtD
Dicyclomine—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00266	0.00326	CcSEcCtD
Dicyclomine—Agitation—Donepezil—Alzheimer's disease	0.00266	0.00326	CcSEcCtD
Dicyclomine—Decreased appetite—Galantamine—Alzheimer's disease	0.00265	0.00324	CcSEcCtD
Dicyclomine—Mental disorder—Memantine—Alzheimer's disease	0.00265	0.00324	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00263	0.00322	CcSEcCtD
Dicyclomine—Fatigue—Galantamine—Alzheimer's disease	0.00263	0.00322	CcSEcCtD
Dicyclomine—Malaise—Donepezil—Alzheimer's disease	0.00261	0.0032	CcSEcCtD
Dicyclomine—Constipation—Galantamine—Alzheimer's disease	0.00261	0.00319	CcSEcCtD
Dicyclomine—Syncope—Donepezil—Alzheimer's disease	0.0026	0.00318	CcSEcCtD
Dicyclomine—Mental disorder—Rivastigmine—Alzheimer's disease	0.00259	0.00317	CcSEcCtD
Dicyclomine—Tension—Memantine—Alzheimer's disease	0.00258	0.00316	CcSEcCtD
Dicyclomine—Erythema—Rivastigmine—Alzheimer's disease	0.00257	0.00315	CcSEcCtD
Dicyclomine—Nervousness—Memantine—Alzheimer's disease	0.00255	0.00313	CcSEcCtD
Dicyclomine—Loss of consciousness—Donepezil—Alzheimer's disease	0.00254	0.00312	CcSEcCtD
Dicyclomine—Tension—Rivastigmine—Alzheimer's disease	0.00252	0.00309	CcSEcCtD
Dicyclomine—Feeling abnormal—Galantamine—Alzheimer's disease	0.00251	0.00308	CcSEcCtD
Dicyclomine—Hypertension—Donepezil—Alzheimer's disease	0.0025	0.00306	CcSEcCtD
Dicyclomine—Nervousness—Rivastigmine—Alzheimer's disease	0.0025	0.00306	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00249	0.00305	CcSEcCtD
Dicyclomine—Vision blurred—Memantine—Alzheimer's disease	0.00248	0.00303	CcSEcCtD
Dicyclomine—Ill-defined disorder—Memantine—Alzheimer's disease	0.00244	0.00299	CcSEcCtD
Dicyclomine—Discomfort—Donepezil—Alzheimer's disease	0.00244	0.00298	CcSEcCtD
Dicyclomine—Vision blurred—Rivastigmine—Alzheimer's disease	0.00242	0.00297	CcSEcCtD
Dicyclomine—Agitation—Memantine—Alzheimer's disease	0.00242	0.00296	CcSEcCtD
Dicyclomine—Dry mouth—Donepezil—Alzheimer's disease	0.00241	0.00295	CcSEcCtD
Dicyclomine—Abdominal pain—Galantamine—Alzheimer's disease	0.00241	0.00295	CcSEcCtD
Dicyclomine—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.00239	0.00292	CcSEcCtD
Dicyclomine—Confusional state—Donepezil—Alzheimer's disease	0.00238	0.00292	CcSEcCtD
Dicyclomine—Malaise—Memantine—Alzheimer's disease	0.00237	0.0029	CcSEcCtD
Dicyclomine—Agitation—Rivastigmine—Alzheimer's disease	0.00236	0.00289	CcSEcCtD
Dicyclomine—Oedema—Donepezil—Alzheimer's disease	0.00236	0.00289	CcSEcCtD
Dicyclomine—Syncope—Memantine—Alzheimer's disease	0.00236	0.00289	CcSEcCtD
Dicyclomine—Shock—Donepezil—Alzheimer's disease	0.00232	0.00285	CcSEcCtD
Dicyclomine—Palpitations—Memantine—Alzheimer's disease	0.00232	0.00284	CcSEcCtD
Dicyclomine—Malaise—Rivastigmine—Alzheimer's disease	0.00232	0.00284	CcSEcCtD
Dicyclomine—Nervous system disorder—Donepezil—Alzheimer's disease	0.00232	0.00284	CcSEcCtD
Dicyclomine—Loss of consciousness—Memantine—Alzheimer's disease	0.00231	0.00283	CcSEcCtD
Dicyclomine—Syncope—Rivastigmine—Alzheimer's disease	0.00231	0.00282	CcSEcCtD
Dicyclomine—Palpitations—Rivastigmine—Alzheimer's disease	0.00227	0.00278	CcSEcCtD
Dicyclomine—Hypertension—Memantine—Alzheimer's disease	0.00227	0.00278	CcSEcCtD
Dicyclomine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.00226	0.00277	CcSEcCtD
Dicyclomine—Anorexia—Donepezil—Alzheimer's disease	0.00225	0.00276	CcSEcCtD
Dicyclomine—Hypersensitivity—Galantamine—Alzheimer's disease	0.00225	0.00275	CcSEcCtD
Dicyclomine—Hypertension—Rivastigmine—Alzheimer's disease	0.00222	0.00272	CcSEcCtD
Dicyclomine—Discomfort—Memantine—Alzheimer's disease	0.00221	0.00271	CcSEcCtD
Dicyclomine—Dry mouth—Memantine—Alzheimer's disease	0.00219	0.00268	CcSEcCtD
Dicyclomine—Asthenia—Galantamine—Alzheimer's disease	0.00219	0.00268	CcSEcCtD
Dicyclomine—Confusional state—Memantine—Alzheimer's disease	0.00216	0.00265	CcSEcCtD
Dicyclomine—Discomfort—Rivastigmine—Alzheimer's disease	0.00216	0.00265	CcSEcCtD
Dicyclomine—Oedema—Memantine—Alzheimer's disease	0.00215	0.00263	CcSEcCtD
Dicyclomine—Dry mouth—Rivastigmine—Alzheimer's disease	0.00214	0.00262	CcSEcCtD
Dicyclomine—Insomnia—Donepezil—Alzheimer's disease	0.00214	0.00262	CcSEcCtD
Dicyclomine—Paraesthesia—Donepezil—Alzheimer's disease	0.00212	0.0026	CcSEcCtD
Dicyclomine—Confusional state—Rivastigmine—Alzheimer's disease	0.00212	0.00259	CcSEcCtD
Dicyclomine—Shock—Memantine—Alzheimer's disease	0.00211	0.00258	CcSEcCtD
Dicyclomine—Dyspnoea—Donepezil—Alzheimer's disease	0.00211	0.00258	CcSEcCtD
Dicyclomine—Nervous system disorder—Memantine—Alzheimer's disease	0.0021	0.00258	CcSEcCtD
Dicyclomine—Somnolence—Donepezil—Alzheimer's disease	0.0021	0.00257	CcSEcCtD
Dicyclomine—Oedema—Rivastigmine—Alzheimer's disease	0.0021	0.00257	CcSEcCtD
Dicyclomine—Tachycardia—Memantine—Alzheimer's disease	0.00209	0.00256	CcSEcCtD
Dicyclomine—Dyspepsia—Donepezil—Alzheimer's disease	0.00208	0.00255	CcSEcCtD
Dicyclomine—Shock—Rivastigmine—Alzheimer's disease	0.00206	0.00253	CcSEcCtD
Dicyclomine—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00206	0.00252	CcSEcCtD
Dicyclomine—Decreased appetite—Donepezil—Alzheimer's disease	0.00205	0.00251	CcSEcCtD
Dicyclomine—Tachycardia—Rivastigmine—Alzheimer's disease	0.00205	0.00251	CcSEcCtD
Dicyclomine—Anorexia—Memantine—Alzheimer's disease	0.00204	0.0025	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00204	0.0025	CcSEcCtD
Dicyclomine—Fatigue—Donepezil—Alzheimer's disease	0.00204	0.00249	CcSEcCtD
Dicyclomine—Constipation—Donepezil—Alzheimer's disease	0.00202	0.00247	CcSEcCtD
Dicyclomine—Pain—Donepezil—Alzheimer's disease	0.00202	0.00247	CcSEcCtD
Dicyclomine—Dizziness—Galantamine—Alzheimer's disease	0.00202	0.00247	CcSEcCtD
Dicyclomine—Anorexia—Rivastigmine—Alzheimer's disease	0.002	0.00245	CcSEcCtD
Dicyclomine—Feeling abnormal—Donepezil—Alzheimer's disease	0.00195	0.00238	CcSEcCtD
Dicyclomine—Insomnia—Memantine—Alzheimer's disease	0.00194	0.00238	CcSEcCtD
Dicyclomine—Vomiting—Galantamine—Alzheimer's disease	0.00194	0.00237	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00193	0.00237	CcSEcCtD
Dicyclomine—Paraesthesia—Memantine—Alzheimer's disease	0.00193	0.00236	CcSEcCtD
Dicyclomine—Rash—Galantamine—Alzheimer's disease	0.00192	0.00235	CcSEcCtD
Dicyclomine—Dermatitis—Galantamine—Alzheimer's disease	0.00192	0.00235	CcSEcCtD
Dicyclomine—Dyspnoea—Memantine—Alzheimer's disease	0.00191	0.00234	CcSEcCtD
Dicyclomine—Headache—Galantamine—Alzheimer's disease	0.00191	0.00234	CcSEcCtD
Dicyclomine—Somnolence—Memantine—Alzheimer's disease	0.00191	0.00233	CcSEcCtD
Dicyclomine—Insomnia—Rivastigmine—Alzheimer's disease	0.0019	0.00232	CcSEcCtD
Dicyclomine—Dyspepsia—Memantine—Alzheimer's disease	0.00189	0.00231	CcSEcCtD
Dicyclomine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.00188	0.00231	CcSEcCtD
Dicyclomine—Urticaria—Donepezil—Alzheimer's disease	0.00188	0.0023	CcSEcCtD
Dicyclomine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00187	0.00229	CcSEcCtD
Dicyclomine—Abdominal pain—Donepezil—Alzheimer's disease	0.00187	0.00229	CcSEcCtD
Dicyclomine—Somnolence—Rivastigmine—Alzheimer's disease	0.00187	0.00228	CcSEcCtD
Dicyclomine—Decreased appetite—Memantine—Alzheimer's disease	0.00186	0.00228	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00185	0.00227	CcSEcCtD
Dicyclomine—Fatigue—Memantine—Alzheimer's disease	0.00185	0.00226	CcSEcCtD
Dicyclomine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00185	0.00226	CcSEcCtD
Dicyclomine—Pain—Memantine—Alzheimer's disease	0.00183	0.00225	CcSEcCtD
Dicyclomine—Constipation—Memantine—Alzheimer's disease	0.00183	0.00225	CcSEcCtD
Dicyclomine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00182	0.00223	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00181	0.00222	CcSEcCtD
Dicyclomine—Nausea—Galantamine—Alzheimer's disease	0.00181	0.00222	CcSEcCtD
Dicyclomine—Fatigue—Rivastigmine—Alzheimer's disease	0.00181	0.00222	CcSEcCtD
Dicyclomine—Constipation—Rivastigmine—Alzheimer's disease	0.00179	0.0022	CcSEcCtD
Dicyclomine—Pain—Rivastigmine—Alzheimer's disease	0.00179	0.0022	CcSEcCtD
Dicyclomine—Feeling abnormal—Memantine—Alzheimer's disease	0.00177	0.00216	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00175	0.00215	CcSEcCtD
Dicyclomine—Hypersensitivity—Donepezil—Alzheimer's disease	0.00174	0.00213	CcSEcCtD
Dicyclomine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00173	0.00212	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.00172	0.0021	CcSEcCtD
Dicyclomine—Urticaria—Memantine—Alzheimer's disease	0.0017	0.00209	CcSEcCtD
Dicyclomine—Abdominal pain—Memantine—Alzheimer's disease	0.0017	0.00208	CcSEcCtD
Dicyclomine—Asthenia—Donepezil—Alzheimer's disease	0.0017	0.00208	CcSEcCtD
Dicyclomine—Pruritus—Donepezil—Alzheimer's disease	0.00167	0.00205	CcSEcCtD
Dicyclomine—Urticaria—Rivastigmine—Alzheimer's disease	0.00167	0.00204	CcSEcCtD
Dicyclomine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.00166	0.00203	CcSEcCtD
Dicyclomine—CHRM2—forebrain—Alzheimer's disease	0.00164	0.0984	CbGeAlD
Dicyclomine—Hypersensitivity—Memantine—Alzheimer's disease	0.00158	0.00194	CcSEcCtD
Dicyclomine—Dizziness—Donepezil—Alzheimer's disease	0.00156	0.00191	CcSEcCtD
Dicyclomine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00155	0.00189	CcSEcCtD
Dicyclomine—Asthenia—Memantine—Alzheimer's disease	0.00154	0.00188	CcSEcCtD
Dicyclomine—Pruritus—Memantine—Alzheimer's disease	0.00152	0.00186	CcSEcCtD
Dicyclomine—Asthenia—Rivastigmine—Alzheimer's disease	0.00151	0.00184	CcSEcCtD
Dicyclomine—CHRM2—telencephalon—Alzheimer's disease	0.00151	0.0904	CbGeAlD
Dicyclomine—Vomiting—Donepezil—Alzheimer's disease	0.0015	0.00184	CcSEcCtD
Dicyclomine—CHRM1—forebrain—Alzheimer's disease	0.00149	0.0895	CbGeAlD
Dicyclomine—Rash—Donepezil—Alzheimer's disease	0.00149	0.00182	CcSEcCtD
Dicyclomine—Dermatitis—Donepezil—Alzheimer's disease	0.00149	0.00182	CcSEcCtD
Dicyclomine—Pruritus—Rivastigmine—Alzheimer's disease	0.00148	0.00182	CcSEcCtD
Dicyclomine—Headache—Donepezil—Alzheimer's disease	0.00148	0.00181	CcSEcCtD
Dicyclomine—Dizziness—Memantine—Alzheimer's disease	0.00142	0.00174	CcSEcCtD
Dicyclomine—Nausea—Donepezil—Alzheimer's disease	0.0014	0.00172	CcSEcCtD
Dicyclomine—Dizziness—Rivastigmine—Alzheimer's disease	0.00139	0.0017	CcSEcCtD
Dicyclomine—CHRM1—telencephalon—Alzheimer's disease	0.00137	0.0823	CbGeAlD
Dicyclomine—Vomiting—Memantine—Alzheimer's disease	0.00136	0.00167	CcSEcCtD
Dicyclomine—Rash—Memantine—Alzheimer's disease	0.00135	0.00166	CcSEcCtD
Dicyclomine—Dermatitis—Memantine—Alzheimer's disease	0.00135	0.00165	CcSEcCtD
Dicyclomine—Headache—Memantine—Alzheimer's disease	0.00134	0.00165	CcSEcCtD
Dicyclomine—Vomiting—Rivastigmine—Alzheimer's disease	0.00133	0.00163	CcSEcCtD
Dicyclomine—CHRM3—forebrain—Alzheimer's disease	0.00133	0.0801	CbGeAlD
Dicyclomine—Rash—Rivastigmine—Alzheimer's disease	0.00132	0.00162	CcSEcCtD
Dicyclomine—Dermatitis—Rivastigmine—Alzheimer's disease	0.00132	0.00162	CcSEcCtD
Dicyclomine—Headache—Rivastigmine—Alzheimer's disease	0.00131	0.00161	CcSEcCtD
Dicyclomine—Nausea—Memantine—Alzheimer's disease	0.00127	0.00156	CcSEcCtD
Dicyclomine—Nausea—Rivastigmine—Alzheimer's disease	0.00125	0.00153	CcSEcCtD
Dicyclomine—CHRM3—telencephalon—Alzheimer's disease	0.00123	0.0737	CbGeAlD
Dicyclomine—CHRM2—nervous system—Alzheimer's disease	0.000889	0.0534	CbGeAlD
Dicyclomine—CHRM2—central nervous system—Alzheimer's disease	0.000856	0.0514	CbGeAlD
Dicyclomine—CHRM1—nervous system—Alzheimer's disease	0.000809	0.0486	CbGeAlD
Dicyclomine—CHRM1—central nervous system—Alzheimer's disease	0.000779	0.0468	CbGeAlD
Dicyclomine—CHRM3—nervous system—Alzheimer's disease	0.000724	0.0435	CbGeAlD
Dicyclomine—CHRM3—central nervous system—Alzheimer's disease	0.000697	0.0419	CbGeAlD
Dicyclomine—CHRM2—brain—Alzheimer's disease	0.000679	0.0408	CbGeAlD
Dicyclomine—CHRM1—brain—Alzheimer's disease	0.000618	0.0371	CbGeAlD
Dicyclomine—CHRM3—brain—Alzheimer's disease	0.000553	0.0332	CbGeAlD
Dicyclomine—CYP1A1—nervous system—Alzheimer's disease	0.000542	0.0326	CbGeAlD
Dicyclomine—CYP1A1—central nervous system—Alzheimer's disease	0.000522	0.0314	CbGeAlD
Dicyclomine—CYP1A1—brain—Alzheimer's disease	0.000414	0.0249	CbGeAlD
Dicyclomine—CHRM1—Signaling Pathways—APH1A—Alzheimer's disease	0.000104	0.000626	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—APH1A—Alzheimer's disease	0.000104	0.000624	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000103	0.000619	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—APH1A—Alzheimer's disease	0.000103	0.000618	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000103	0.000617	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000102	0.000611	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—A2M—Alzheimer's disease	0.000102	0.00061	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NCSTN—Alzheimer's disease	0.000102	0.000609	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NCSTN—Alzheimer's disease	0.000101	0.000608	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NCSTN—Alzheimer's disease	0.0001	0.000602	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—LRP1—Alzheimer's disease	9.9e-05	0.000594	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—LRP1—Alzheimer's disease	9.87e-05	0.000592	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	9.86e-05	0.000592	CbGpPWpGaD
Dicyclomine—CHRM1—Circadian rythm related genes—TP53—Alzheimer's disease	9.78e-05	0.000587	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—LRP1—Alzheimer's disease	9.78e-05	0.000587	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—GAL—Alzheimer's disease	9.67e-05	0.000581	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—GFAP—Alzheimer's disease	9.67e-05	0.000581	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—GFAP—Alzheimer's disease	9.64e-05	0.000579	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—GAL—Alzheimer's disease	9.64e-05	0.000579	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—GAL—Alzheimer's disease	9.55e-05	0.000573	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—GFAP—Alzheimer's disease	9.55e-05	0.000573	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CHAT—Alzheimer's disease	9.06e-05	0.000544	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—TPI1—Alzheimer's disease	9.06e-05	0.000544	CbGpPWpGaD
Dicyclomine—CHRM1—Circadian rythm related genes—IL6—Alzheimer's disease	8.96e-05	0.000538	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—ACHE—Alzheimer's disease	8.84e-05	0.000531	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—INPP5D—Alzheimer's disease	8.74e-05	0.000525	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—MAOB—Alzheimer's disease	8.68e-05	0.000521	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—A2M—Alzheimer's disease	8.52e-05	0.000512	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—A2M—Alzheimer's disease	8.5e-05	0.00051	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	8.49e-05	0.000509	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	8.46e-05	0.000508	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—A2M—Alzheimer's disease	8.41e-05	0.000505	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—PRKCG—Alzheimer's disease	8.4e-05	0.000504	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—PRKCG—Alzheimer's disease	8.38e-05	0.000503	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GAPDH—Alzheimer's disease	8.36e-05	0.000502	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—PRKCG—Alzheimer's disease	8.3e-05	0.000498	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—ENO1—Alzheimer's disease	8.28e-05	0.000497	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PTGS1—Alzheimer's disease	8.28e-05	0.000497	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	8.26e-05	0.000496	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PSEN2—Alzheimer's disease	8.26e-05	0.000496	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PSEN2—Alzheimer's disease	8.23e-05	0.000494	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	8.19e-05	0.000491	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PSEN2—Alzheimer's disease	8.15e-05	0.000489	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CYP2D6—Alzheimer's disease	8.12e-05	0.000488	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—A2M—Alzheimer's disease	8.07e-05	0.000485	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—CCR5—Alzheimer's disease	7.96e-05	0.000478	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—CCR5—Alzheimer's disease	7.94e-05	0.000476	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—CCR5—Alzheimer's disease	7.86e-05	0.000472	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—HTR2A—Alzheimer's disease	7.79e-05	0.000468	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—HTR2A—Alzheimer's disease	7.77e-05	0.000466	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—BCHE—Alzheimer's disease	7.7e-05	0.000462	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—HTR2A—Alzheimer's disease	7.69e-05	0.000462	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PRKCG—Alzheimer's disease	7.63e-05	0.000458	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PRKCG—Alzheimer's disease	7.61e-05	0.000457	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NPY—Alzheimer's disease	7.6e-05	0.000456	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NPY—Alzheimer's disease	7.57e-05	0.000455	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IAPP—Alzheimer's disease	7.55e-05	0.000453	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PRKCG—Alzheimer's disease	7.53e-05	0.000452	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IAPP—Alzheimer's disease	7.53e-05	0.000452	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NPY—Alzheimer's disease	7.5e-05	0.00045	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IAPP—Alzheimer's disease	7.45e-05	0.000447	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CRH—Alzheimer's disease	7.33e-05	0.00044	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CRH—Alzheimer's disease	7.31e-05	0.000439	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PLCB1—Alzheimer's disease	7.27e-05	0.000436	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CRH—Alzheimer's disease	7.24e-05	0.000434	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—CCR5—Alzheimer's disease	7.23e-05	0.000434	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—CCR5—Alzheimer's disease	7.21e-05	0.000433	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	7.2e-05	0.000432	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—CCR5—Alzheimer's disease	7.14e-05	0.000428	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—HTR2A—Alzheimer's disease	7.08e-05	0.000425	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—HTR2A—Alzheimer's disease	7.05e-05	0.000423	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—ABCA1—Alzheimer's disease	7.04e-05	0.000423	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ACHE—Alzheimer's disease	7.02e-05	0.000422	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—HTR2A—Alzheimer's disease	6.99e-05	0.000419	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NPS—Alzheimer's disease	6.95e-05	0.000417	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—INPP5D—Alzheimer's disease	6.94e-05	0.000417	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NPS—Alzheimer's disease	6.93e-05	0.000416	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PPP3CA—Alzheimer's disease	6.91e-05	0.000415	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PPP3CA—Alzheimer's disease	6.89e-05	0.000414	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NPS—Alzheimer's disease	6.86e-05	0.000412	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—F2—Alzheimer's disease	6.83e-05	0.00041	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PPP3CA—Alzheimer's disease	6.83e-05	0.00041	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PTK2B—Alzheimer's disease	6.81e-05	0.000409	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—F2—Alzheimer's disease	6.81e-05	0.000409	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PTK2B—Alzheimer's disease	6.79e-05	0.000408	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—F2—Alzheimer's disease	6.74e-05	0.000405	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PTK2B—Alzheimer's disease	6.73e-05	0.000404	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SST—Alzheimer's disease	6.63e-05	0.000398	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—GAB2—Alzheimer's disease	6.63e-05	0.000398	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NTRK2—Alzheimer's disease	6.63e-05	0.000398	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—GAB2—Alzheimer's disease	6.61e-05	0.000397	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SST—Alzheimer's disease	6.61e-05	0.000397	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NTRK2—Alzheimer's disease	6.61e-05	0.000397	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—CALM1—Alzheimer's disease	6.6e-05	0.000396	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—CALM1—Alzheimer's disease	6.58e-05	0.000395	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ENO1—Alzheimer's disease	6.58e-05	0.000395	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PTGS1—Alzheimer's disease	6.58e-05	0.000395	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—GSK3A—Alzheimer's disease	6.57e-05	0.000394	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—GSK3A—Alzheimer's disease	6.55e-05	0.000393	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NTRK2—Alzheimer's disease	6.54e-05	0.000393	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—GAB2—Alzheimer's disease	6.54e-05	0.000393	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SST—Alzheimer's disease	6.54e-05	0.000393	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—CALM1—Alzheimer's disease	6.52e-05	0.000391	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—GSK3A—Alzheimer's disease	6.49e-05	0.000389	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—APP—Alzheimer's disease	6.46e-05	0.000388	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CYP2D6—Alzheimer's disease	6.45e-05	0.000387	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—APP—Alzheimer's disease	6.44e-05	0.000387	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—APP—Alzheimer's disease	6.38e-05	0.000383	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—F2—Alzheimer's disease	6.2e-05	0.000372	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—F2—Alzheimer's disease	6.18e-05	0.000371	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—F2—Alzheimer's disease	6.12e-05	0.000368	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—BCHE—Alzheimer's disease	6.12e-05	0.000367	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PLCB1—Alzheimer's disease	6.1e-05	0.000366	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PLCB1—Alzheimer's disease	6.08e-05	0.000365	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PPARGC1A—Alzheimer's disease	6.07e-05	0.000364	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—HMOX1—Alzheimer's disease	6.04e-05	0.000363	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PLCB1—Alzheimer's disease	6.02e-05	0.000361	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PLCB1—Alzheimer's disease	5.77e-05	0.000347	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NGFR—Alzheimer's disease	5.69e-05	0.000341	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NGFR—Alzheimer's disease	5.67e-05	0.00034	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	5.66e-05	0.00034	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—CREB1—Alzheimer's disease	5.65e-05	0.000339	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—CREB1—Alzheimer's disease	5.63e-05	0.000338	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NGFR—Alzheimer's disease	5.61e-05	0.000337	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ABCA1—Alzheimer's disease	5.6e-05	0.000336	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—CREB1—Alzheimer's disease	5.58e-05	0.000335	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ADAM10—Alzheimer's disease	5.56e-05	0.000333	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ADAM10—Alzheimer's disease	5.54e-05	0.000332	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—CCL2—Alzheimer's disease	5.53e-05	0.000332	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—LPL—Alzheimer's disease	5.53e-05	0.000332	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—CCL2—Alzheimer's disease	5.51e-05	0.000331	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ADAM10—Alzheimer's disease	5.48e-05	0.000329	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—CCL2—Alzheimer's disease	5.46e-05	0.000328	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—S100B—Alzheimer's disease	5.25e-05	0.000315	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—S100B—Alzheimer's disease	5.24e-05	0.000314	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—S100B—Alzheimer's disease	5.19e-05	0.000311	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IGF2—Alzheimer's disease	5e-05	0.0003	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IGF2—Alzheimer's disease	4.99e-05	0.000299	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—MTHFR—Alzheimer's disease	4.98e-05	0.000299	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IGF2—Alzheimer's disease	4.94e-05	0.000296	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IGF1R—Alzheimer's disease	4.84e-05	0.00029	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PPARGC1A—Alzheimer's disease	4.82e-05	0.000289	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IGF1R—Alzheimer's disease	4.82e-05	0.000289	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—HMOX1—Alzheimer's disease	4.8e-05	0.000288	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IGF1R—Alzheimer's disease	4.77e-05	0.000287	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CALM1—Alzheimer's disease	4.65e-05	0.000279	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—LPL—Alzheimer's disease	4.64e-05	0.000278	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—APOE—Alzheimer's disease	4.63e-05	0.000278	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—LPL—Alzheimer's disease	4.62e-05	0.000277	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MEF2C—Alzheimer's disease	4.59e-05	0.000276	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CAV1—Alzheimer's disease	4.59e-05	0.000276	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MEF2C—Alzheimer's disease	4.58e-05	0.000275	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—LPL—Alzheimer's disease	4.58e-05	0.000275	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MEF2C—Alzheimer's disease	4.54e-05	0.000272	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PRKCG—Alzheimer's disease	4.51e-05	0.000271	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PRKCG—Alzheimer's disease	4.49e-05	0.00027	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PRKCG—Alzheimer's disease	4.45e-05	0.000267	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NGF—Alzheimer's disease	4.39e-05	0.000264	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—LPL—Alzheimer's disease	4.39e-05	0.000264	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NGF—Alzheimer's disease	4.38e-05	0.000263	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NGF—Alzheimer's disease	4.33e-05	0.00026	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CCR5—Alzheimer's disease	4.27e-05	0.000256	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CCR5—Alzheimer's disease	4.26e-05	0.000256	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CCR5—Alzheimer's disease	4.22e-05	0.000253	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HTR2A—Alzheimer's disease	4.18e-05	0.000251	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HTR2A—Alzheimer's disease	4.17e-05	0.00025	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HTR2A—Alzheimer's disease	4.13e-05	0.000248	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PPARG—Alzheimer's disease	4.04e-05	0.000242	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—INS—Alzheimer's disease	3.96e-05	0.000238	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—MTHFR—Alzheimer's disease	3.95e-05	0.000237	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CALM1—Alzheimer's disease	3.9e-05	0.000234	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CALM1—Alzheimer's disease	3.89e-05	0.000233	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—LEP—Alzheimer's disease	3.89e-05	0.000233	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—APOE—Alzheimer's disease	3.89e-05	0.000233	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—APOE—Alzheimer's disease	3.87e-05	0.000233	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—LEP—Alzheimer's disease	3.87e-05	0.000233	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CAV1—Alzheimer's disease	3.85e-05	0.000231	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CALM1—Alzheimer's disease	3.85e-05	0.000231	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CAV1—Alzheimer's disease	3.84e-05	0.00023	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—LEP—Alzheimer's disease	3.84e-05	0.00023	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—APOE—Alzheimer's disease	3.84e-05	0.00023	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CAV1—Alzheimer's disease	3.8e-05	0.000228	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ESR1—Alzheimer's disease	3.71e-05	0.000223	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ESR1—Alzheimer's disease	3.7e-05	0.000222	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CALM1—Alzheimer's disease	3.69e-05	0.000222	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—APOE—Alzheimer's disease	3.68e-05	0.000221	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—F2—Alzheimer's disease	3.67e-05	0.00022	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ESR1—Alzheimer's disease	3.66e-05	0.00022	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—F2—Alzheimer's disease	3.65e-05	0.000219	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CAV1—Alzheimer's disease	3.65e-05	0.000219	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—F2—Alzheimer's disease	3.62e-05	0.000217	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	3.59e-05	0.000215	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NOTCH1—Alzheimer's disease	3.58e-05	0.000215	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NOTCH1—Alzheimer's disease	3.54e-05	0.000213	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—NOS3—Alzheimer's disease	3.47e-05	0.000208	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—GSK3B—Alzheimer's disease	3.37e-05	0.000202	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—GSK3B—Alzheimer's disease	3.36e-05	0.000201	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CREB1—Alzheimer's disease	3.34e-05	0.0002	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CREB1—Alzheimer's disease	3.33e-05	0.0002	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	3.32e-05	0.000199	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—INS—Alzheimer's disease	3.32e-05	0.000199	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—INS—Alzheimer's disease	3.31e-05	0.000199	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	3.3e-05	0.000198	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—INS—Alzheimer's disease	3.28e-05	0.000197	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CCL2—Alzheimer's disease	3.27e-05	0.000196	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CCL2—Alzheimer's disease	3.26e-05	0.000195	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	3.22e-05	0.000194	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IGF1—Alzheimer's disease	3.21e-05	0.000193	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PPARG—Alzheimer's disease	3.21e-05	0.000192	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IGF1—Alzheimer's disease	3.2e-05	0.000192	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PTGS2—Alzheimer's disease	3.17e-05	0.000191	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	3.17e-05	0.00019	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—INS—Alzheimer's disease	3.14e-05	0.000189	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NOS3—Alzheimer's disease	2.91e-05	0.000175	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NOS3—Alzheimer's disease	2.9e-05	0.000174	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	2.87e-05	0.000173	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—NOS3—Alzheimer's disease	2.76e-05	0.000166	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PTGS2—Alzheimer's disease	2.52e-05	0.000151	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.49e-05	0.00015	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—AKT1—Alzheimer's disease	2.49e-05	0.000149	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CASP3—Alzheimer's disease	2.47e-05	0.000148	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CASP3—Alzheimer's disease	2.46e-05	0.000148	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	2.46e-05	0.000148	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—IL6—Alzheimer's disease	2.46e-05	0.000147	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—IL6—Alzheimer's disease	2.45e-05	0.000147	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	2.44e-05	0.000146	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	2.42e-05	0.000146	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MAPK8—Alzheimer's disease	2.27e-05	0.000136	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—AKT1—Alzheimer's disease	2.27e-05	0.000136	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MAPK8—Alzheimer's disease	2.26e-05	0.000136	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—AKT1—Alzheimer's disease	2.26e-05	0.000136	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	2.24e-05	0.000135	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	2.24e-05	0.000134	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—VEGFA—Alzheimer's disease	2.1e-05	0.000126	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—VEGFA—Alzheimer's disease	2.09e-05	0.000126	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	2.07e-05	0.000124	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TGFB1—Alzheimer's disease	1.93e-05	0.000116	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TGFB1—Alzheimer's disease	1.92e-05	0.000115	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	1.9e-05	0.000114	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—AKT1—Alzheimer's disease	1.6e-05	9.58e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TP53—Alzheimer's disease	1.58e-05	9.51e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TP53—Alzheimer's disease	1.58e-05	9.48e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	1.56e-05	9.39e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IL6—Alzheimer's disease	1.45e-05	8.71e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IL6—Alzheimer's disease	1.45e-05	8.68e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	1.43e-05	8.6e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AKT1—Alzheimer's disease	1.34e-05	8.03e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AKT1—Alzheimer's disease	1.33e-05	8.01e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	1.32e-05	7.93e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—AKT1—Alzheimer's disease	1.27e-05	7.61e-05	CbGpPWpGaD
